Teva Announces $1.5 Billion Debt Tender Offer
On Thursday, the Israeli drugmaker published its third quarter reports for 2019, reporting it had cut down its net debt to $25.7 billion
Sophie Shulman | 10:29 10.11.2019
On Friday, one day after publishing its earnings reports for the third quarter, Teva Pharmaceutical Industries Ltd. announced a debt tender offer of up to $1.5 billion, with senior notes offered in both dollars and euros. Teva has estimated it may list the newly issued bonds in the future. Teva closed up 9.8% on NYSE Friday, after jumping Thursday following CEO Kåre Schultz’s statement that the company’s profitability might improve in 2020.